Mounting research from around the world suggests marijuana's potential to treat multiple medical conditions ranging from chronic pain to cancer, epilepsy, HIV/AIDS, anxiety and more.
Marijuana Investing
The Average Marijuana Stock Price Is Up Over 300% In The Past Year
Investing in marijuana seems to be the current trend as high returns have been noted across the board, however, Investors have, in the past year, been spoiled by incredibly high yields since the stock market’s bounce back after 2008. The three major U.S. indexes have tripled in value, with the NASDAQ Composite reaching almost four times what it was in 2009.
Isodiol International Inc. Announces Unaudited Quarterly Profit of Iso International LLC
Isodiol International Inc. (CSE:ISOL) (OTC:LAGBF) (Frankfurt:LB6A.F) a global cannabis innovator, specializing in the development of pharmaceutical and consumer products, announces the operational numbers of its wholly-owned subsidiary for the period from April 1, 2017 to June 30, 2017.
ChineseInvestors.com, Inc. (CIIX) Subsidiary Files Record of ‘CBD Magic Hemp Series’ Product Line Ahead of Impending Launch
Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that its wholly-owned foreign enterprise, CBD Biotechnology Co. Ltd., has officially filed a record of its first line of non-industrial hemp-infused skin care products with the China Food and Drug Administration (CFDA).
Aurora Cannabis : Starts Trading on Toronto Stock Exchange
Aurora Cannabis Inc. (the "Company" or "Aurora") (TSXV: ACB) (OTCQX: ACBFF) ( Frankfurt : 21P; WKN: A1C4WM) announced today that common shares of the Company will commence trading on Toronto Stock Exchange (the "TSX") effective Monday July 24 . Common shares will continue to trade under the symbol "ACB".
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Commences Lab Work with National Research Council of Canada
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced the start of laboratory work under its collaborative research project with the National Research Council of Canada (“NRC”).
Lotus Announces Construction Start, Private Placement and Terms of Cannabis Wheaton Streaming Deal
Lotus Ventures Inc. (“Lotus” or the “Company”) (CSE:J) is pleased to announce a non-brokered private placement offering (the “Offering”), the start of facility construction, provide details on its streaming agreement with Cannabis Wheaton Income Corp. (“CBW”) and an update on the regulatory licensing process.
The strategic approach of ABcann’s growth technique
Aaron Keay, CEO of ABcann Global Corporation, speaks with Natasha Frakes about why the company waited two years from getting their license before going public.
Legal Cannabis and Hemp Based Product Sales Projected to Grow
According to a research report by Ameri Research Inc., the global legal cannabis market was valued at $14.3 billion in 2016 and is projected to grow at a CAGR of 21.1% from 2017 to 2024. By 2024, the projected demand of cannabis will continue to rise for both recreational and medical use, while reaching an estimated global sales value of $63.5 billion .
India Globalization Capital, Inc. (NYSE: IGC) Reports Financial Results for Fiscal Year Ended March 31, 2017
India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its financial results for the fiscal year ended March 31, 2017.
Kush Bottles Reports Third Quarter Fiscal 2017 Results
SANTA ANA, Calif. Kush Bottles, Inc. (OTCQB: KSHB), a dynamic sales platform that provides unique products and services for both businesses and consumers in the cannabis industry, today reported financial results for its third fiscal quarter ended May 31, 2017 .
Aphria gets price target raise to $13.00 at Clarus Securities
A better than expected quarter has Clarus analyst Noel Atkinson raising his price target on Aphria (TSXV:APH).
On Wednesday, Aphria reported its Q4 and fiscal 2017 results. In the fourth quarter, the company lost $2.6-million on revenue of $5.7-million, a topline that was up 106 per cent over the same period last year.
ABcann Global Announces Listing on the OTCQB Marketplace and the Frankfurt Stock Exchange
The Company expects to benefit from being listed on the OTCQB and the FSE by gaining greater visibility and convenience of trading the Company’s common shares to US and European investors, allowing a much larger potential shareholder base and enhanced liquidity.
Medical Marijuana, Inc. Announces Largest Revenue Quarter and Sales Month in Company History, 269% Revenue Increase From Q2 2016
Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the second quarter of 2017 generated the largest revenue quarter in the Company's history. Additionally, the Company celebrated the largest-ever single month of revenue in June 2017 as well as the largest sales month and quarter for wholly owned subsidiary Kannaway.
InMed Pharmaceuticals, Inc. (CSE: In) (OTCQB: Imlff) Enters Research and Development Collaboration with Atera Sas
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its entry into a research and development collaboration with ATERA SAS of France, a leading tissue engineering company specializing in the development of advanced human tissue models.